388
Views
10
CrossRef citations to date
0
Altmetric
Review

Interventions to Improve Adherence to Cardiovascular Medication: What About Gender Differences? A Systematic Literature Review

, ORCID Icon, ORCID Icon, , & ORCID Icon
Pages 2055-2070 | Published online: 29 Oct 2020

References

  • WHO. Available from: https://www.who.int/health-topics/cardiovascular-diseases#tab=tab_1. Accessed 21 April, 2020.
  • Patnode CD, Evans CV, Senger CA, Redmond N, Lin JS. Behavioral Counseling to Promote a Healthful Diet and Physical Activity for Cardiovascular Disease Prevention in Adults Without Known Cardiovascular Disease Risk Factors: Updated Systematic Review for the U.S. Preventive Services Task Force. Rockville MD; 2017.
  • Fleming P, Godwin M. Lifestyle interventions in primary care: systematic review of randomized controlled trials. Can Fam Physician. 2008;54(12):1706–1713.
  • Goldstein KM, Zullig LL, Bastian LA, Bosworth HB. Statin Adherence: does Gender Matter? Current Atherosclerosis Reports. 2016;18(11):63. doi:10.1007/s11883-016-0619-9
  • Saeed A, Kampangkaew J, Nambi V. Prevention of Cardiovascular Disease in Women. Methodist Debakey Cardiovasc J. 2017;13(4):185–192.
  • Virani SS, Woodard LD, Ramsey DJ, et al. Gender disparities in evidence-based statin therapy in patients with cardiovascular disease. The American Journal of Cardiology. 2015;115(1):21–26. doi:10.1016/j.amjcard.2014.09.041
  • Ballo P, Balzi D, Barchielli A, Turco L, Franconi F, Zuppiroli A. Gender differences in statin prescription rates, adequacy of dosing, and association of statin therapy with outcome after heart failure hospitalization: a retrospective analysis in a community setting. European Journal of Clinical Pharmacology. 2016;72(3):311–319. doi:10.1007/s00228-015-1980-2
  • Leifheit-Limson EC, D’Onofrio G, Daneshvar M, et al. Sex Differences in Cardiac Risk Factors, Perceived Risk, and Health Care Provider Discussion of Risk and Risk Modification Among Young Patients With Acute Myocardial Infarction: the VIRGO Study. Journal of the American College of Cardiology. 2015;66(18):1949–1957. doi:10.1016/j.jacc.2015.08.859
  • Ljungman C, Kahan T, Schioler L, et al. Antihypertensive treatment and control according to gender, education, country of birth and psychiatric disorder: the Swedish Primary Care Cardiovascular Database (SPCCD). Journal of Human Hypertension. 2015;29(6):385–393. doi:10.1038/jhh.2014.100
  • Manteuffel M, Williams S, Chen W, Verbrugge RR, Pittman DG, Steinkellner A. Influence of patient sex and gender on medication use, adherence, and prescribing alignment with guidelines. Journal of Women’s Health (2002). 2014;23(2):112–119. doi:10.1089/jwh.2012.3972
  • Franconi F, Campesi I. Sex and gender influences on pharmacological response: an overview. Expert Review of Clinical Pharmacology. 2014;7(4):469–485. doi:10.1586/17512433.2014.922866
  • Chen SL, Lee WL, Liang T, Liao IC. Factors associated with gender differences in medication adherence: a longitudinal study. J Adv Nurs. 2014;70(9):2031–2040. doi:10.1111/jan.12361
  • Vrijens B, De Geest S, Hughes DA, et al. A new taxonomy for describing and defining adherence to medications. British Journal of Clinical Pharmacology. 2012;73(5):691–705. doi:10.1111/j.1365-2125.2012.04167.x
  • Ek S. Gender differences in health information behaviour: a Finnish population-based survey. Health Promotion International. 2015;30(3):736–745. doi:10.1093/heapro/dat063
  • Dawson KA, Schneider MA, Fletcher PC, Bryden PJ. Examining gender differences in the health behaviors of Canadian university students. The Journal of the Royal Society for the Promotion of Health. 2007;127(1):38–44. doi:10.1177/1466424007073205
  • Lewey J, Shrank WH, Bowry AD, Kilabuk E, Brennan TA, Choudhry NK. Gender and racial disparities in adherence to statin therapy: a meta-analysis. Am Heart J. 2013;165(5):665–678. doi:10.1016/j.ahj.2013.02.011
  • Ingersgaard MVHAT, Norgaard O, Grabowski D, Olesen K, Olesen K. Reasons for Nonadherence to Statins – A Systematic Review of Reviews. Patient Prefer Adherence. 2020;14:675–691. doi:10.2147/PPA.S245365
  • Ofori-Asenso R, Jakhu A, Curtis AJ, et al. A Systematic Review and Meta-analysis of the Factors Associated With Nonadherence and Discontinuation of Statins Among People Aged ≥65 Years. J Gerontol a Biol Sci Med Sci. 2018;73(6):798–805. doi:10.1093/gerona/glx256
  • Holmes HM, Luo R, Hanlon JT, Elting LS, Suarez-Almazor M, Goodwin JS. Ethnic disparities in adherence to antihypertensive medications of medicare part D beneficiaries. J Am Geriatr Soc. 2012;60(7):1298–1303. doi:10.1111/j.1532-5415.2012.04037.x
  • Holt E, Joyce C, Dornelles A, et al. Sex differences in barriers to antihypertensive medication adherence: findings from the cohort study of medication adherence among older adults. J Am Geriatr Soc. 2013;61(4):558–564. doi:10.1111/jgs.12171
  • Karalis DG, Wild RA, Maki KC, et al. Gender differences in side effects and attitudes regarding statin use in the Understanding Statin Use in America and Gaps in Patient Education (USAGE) study. J Clin Lipidol. 2016;10(4):833–841. doi:10.1016/j.jacl.2016.02.016
  • Billimek J, Malik S, Sorkin DH, et al. Understanding disparities in lipid management among patients with type 2 diabetes: gender differences in medication nonadherence after treatment intensification. Women’s Health Issues: Official Publication of the Jacobs Institute of Women’s Health. 2015;25(1):6–12. doi:10.1016/j.whi.2014.09.004
  • Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Medicine. 2009;6(7):e1000097. doi:10.1371/journal.pmed.1000097
  • De Geest S, Zullig LL, Dunbar-Jacob J, et al. ESPACOMP Medication Adherence Reporting Guideline (EMERGE). Ann Intern Med. 2018;169(1):30–35. doi:10.7326/M18-0543
  • Derose SF, Green K, Marrett E, et al. Automated outreach to increase primary adherence to cholesterol-lowering medications. JAMA Intern Med. 2013;173(1):38–43. doi:10.1001/2013.jamainternmed.717
  • Eussen SR, van der Elst ME, Klungel OH, et al. A pharmaceutical care program to improve adherence to statin therapy: a randomized controlled trial. The Annals of Pharmacotherapy. 2010;44(12):1905–1913. doi:10.1345/aph.1P281
  • Patel A, Cass A, Peiris D, et al. A pragmatic randomized trial of a polypill-based strategy to improve use of indicated preventive treatments in people at high cardiovascular disease risk. European Journal of Preventive Cardiology. 2015;22(7):920–930. doi:10.1177/2047487314530382
  • Selak V, Elley CR, Bullen C, et al. Effect of fixed dose combination treatment on adherence and risk factor control among patients at high risk of cardiovascular disease: randomised controlled trial in primary care. BMJ (Clinical Research Ed. 2014;348:g3318.
  • Vollmer WM, Owen-Smith AA, Tom JO, et al. Improving adherence to cardiovascular disease medications with information technology. The American Journal of Managed Care. 2014;20(11 Spec No. 17):502–510.
  • Wald DS, Bestwick JP, Raiman L, Brendell R, Wald NJ. Randomised trial of text messaging on adherence to cardiovascular preventive treatment (INTERACT trial). PLoS One. 2014;9(12):e114268. doi:10.1371/journal.pone.0114268
  • Choudhry NK, Isaac T, Lauffenburger JC, et al. Effect of a Remotely Delivered Tailored Multicomponent Approach to Enhance Medication Taking for Patients With Hyperlipidemia, Hypertension, and Diabetes: the STIC2IT Cluster Randomized Clinical Trial. JAMA Intern Med. 2018;178(9):1182–1189. doi:10.1001/jamainternmed.2018.3189
  • Schulz M, Griese-Mammen N, Anker SD, et al. Pharmacy-based interdisciplinary intervention for patients with chronic heart failure: results of the PHARM-CHF randomized controlled trial. Eur J Heart Fail. 2019;21(8):1012–1021. doi:10.1002/ejhf.1503
  • Volpp KG, Troxel AB, Mehta SJ, et al. Effect of Electronic Reminders, Financial Incentives, and Social Support on Outcomes After Myocardial Infarction: the HeartStrong Randomized Clinical Trial. JAMA Intern Med. 2017;177(8):1093–1101. doi:10.1001/jamainternmed.2017.2449
  • Kooy MJ, van Wijk BL, Heerdink ER, de Boer A, Bouvy ML. Does the use of an electronic reminder device with or without counseling improve adherence to lipid-lowering treatment? The results of a randomized controlled trial. Frontiers in Pharmacology. 2013;4:69. doi:10.3389/fphar.2013.00069
  • Blackburn DF, Evans CD, Eurich DT, et al. Community Pharmacists Assisting in Total Cardiovascular Health (CPATCH): A Cluster-Randomized, Controlled Trial Testing a Focused Adherence Strategy Involving Community Pharmacies. Pharmacotherapy. 2016;36(10):1055–1064. doi:10.1002/phar.1831
  • Reddy A, Huseman TL, Canamucio A, et al. Patient and Partner Feedback Reports to Improve Statin Medication Adherence: A Randomized Control Trial. J Gen Intern Med. 2017;32(3):256–261. doi:10.1007/s11606-016-3858-0
  • Jarbol DE, Larsen PV, Gyrd-Hansen D, et al. Determinants of preferences for lifestyle changes versus medication and beliefs in ability to maintain lifestyle changes. A population-based survey. Preventive Medicine Reports. 2017;6:66–73. doi:10.1016/j.pmedr.2017.02.010
  • Puskas CM, Forrest JI, Parashar S, et al. Women and vulnerability to HAART non-adherence: a literature review of treatment adherence by gender from 2000 to 2011. Current HIV/AIDS Reports. 2011;8(4):277–287. doi:10.1007/s11904-011-0098-0
  • Emilsson M, Berndtsson I, Lotvall J, et al. The influence of personality traits and beliefs about medicines on adherence to asthma treatment. Primary Care Respiratory Journal: Journal of the General Practice Airways Group. 2011;20(2):141–147. doi:10.4104/pcrj.2011.00005
  • Sikorskii A, Given CW, Given BA, et al. Do treatment patterns alter beliefs cancer patients hold regarding oral oncolytic agents? Psycho-Oncology. 2018;27(3):1005–1012. doi:10.1002/pon.4606
  • Sajatovic M, Micula-Gondek W, Tatsuoka C, Bialko C. The relationship of gender and gender identity to treatment adherence among individuals with bipolar disorder. Gender Medicine. 2011;8(4):261–268. doi:10.1016/j.genm.2011.06.002
  • Gerlach LB, Kavanagh J, Watkins D, Chiang C, Kim HM, Kales HC. With a little help from my friends?: racial and gender differences in the role of social support in later-life depression medication adherence. International Psychogeriatrics. 2017;29(9):1485–1493. doi:10.1017/S104161021700076X
  • Emilsson M, Gustafsson PA, Ohnstrom G, Marteinsdottir I. Beliefs regarding medication and side effects influence treatment adherence in adolescents with attention deficit hyperactivity disorder. European Child & Adolescent Psychiatry. 2017;26(5):559–571. doi:10.1007/s00787-016-0919-1
  • Allemann SS, Nieuwlaat R, Navarro T, Haynes B, Hersberger KE, Arnet I. Congruence between patient characteristics and interventions may partly explain medication adherence intervention effectiveness: an analysis of 190 randomized controlled trials from a Cochrane systematic review. J Clin Epidemiol. 2017;91:70–79. doi:10.1016/j.jclinepi.2017.07.011
  • Hugtenburg JG, Timmers L, Elders PJ, Vervloet M, van Dijk L. Definitions, variants, and causes of nonadherence with medication: a challenge for tailored interventions. Patient Prefer Adherence. 2013;7:675–682. doi:10.2147/PPA.S29549
  • Nieuwlaat R, Wilczynski N, Navarro T, et al. Interventions for enhancing medication adherence. The Cochrane Database of Systematic Reviews. 2014;11:Cd000011.